To study the effect of various combinations of haart in CD4+ cell count in HIV patient at RIMS, Ranchi Art Centre

Sumit Kumar Mahato, Uma Shanker Prasad Keshri, Akhilesh Kumar, Pholgu Protim, Vineet Kumar


Background: India has the third largest HIV epidemic in the world. In 2013, HIV prevalence in India was an estimated 0.3%, an estimated 130,000 people died from AIDS-related illnesses. Overall, India’s HIV epidemic is slowing down, with a 19% decline in new HIV infections (130,000 in 2013), and a 38% decline in AIDS-related deaths between 2005 and 2013. Antiretroviral therapy (ART) for the treatment of HIV infection has improved steadily since the advent of potent combination therapy in 1996. ART has dramatically reduced HIV-associated morbidity and mortality. The aim of this study is to see the change in CD4+ count in patient taking various combination of HAART (Highly active anti-retroviral treatment).

Methods: A total of 215 patients were included in this study that came to the rims art centre for regular follow up and there cd4+ count at 6 monthly interval upto 18 months was taken and analysed.

Results: The patients were evaluated for their change in CD4+ cell count. Mean of CD4+ count at 6 monthly interval was taken in this study which showed that haart combination causes significant improvement in cd4+ count in each group (1) stavudine, lamivudine, nevirapine (2)stavudine, lamivudine, efavirenz (3) zidovudine, lamivudine, nevirapine (4) zidovudine, lamivudine, efavirenz, (5) tenofovir, lamivudine, efavirenz.

Conclusions: SLN combination was found most effective in increasing the CD4+ Cell count in comparision to the other combination. Other drugs combinations in decreasing order are as follows- SLE, ZLE, TLE, ZLN. 


CD4+ cell count, Highly active anti-retroviral treatment, Lamivudine, Nevirapine, Stavudine

Full Text:



Phillips A, CASCADe Collaboration. Short-term risk of AIDS according to current CD4 cell count and viral load in antiretroviral drugnaive individuals and those treated in the monotherapy era. AIDS, 2004;18(1):51-8.

UNAIDS. The Gap report. 2014.

Medical bulletin/HIV AND AIDS IN INDIA-2016. Available at

Lewden C, Chene G, Morlat P. HIV-infected adults with a CD4 cell count greater than 500 cells/mm3 on long-term combination antiretroviral therapy reach same mortality rates as the general population. J Acquir Immune Defic Syndr. 2007;46:72-7.

Gupta SB, Pujari SN, Joshi SR, Patel AK, For expert panel of Guidelines Development Committee - API Consensus Guidelines for use of Antiretroviral Therapy in Adults (API-ART Guidelines)- Journal Association of Physicians of India. 2006;54:57-74.

Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. Department of Health and Human Services, USA. 2008;1-128.

British HIV Association HIV Medicine. 2006;7:487-503. Available at (

Guidelines for Management of HIV-Infected Adults and Adolescents Including Post-exposure Prophylaxis, NACO. Ministry of health and Family Welfare; 2007.

Egger M, May M, Chene G. Prognosis of HIV-1 infected patients starting highly active antiretroviral therapy: a collaborative analysis of retrospective studies. 2002;360:119-29.

Stilianakis NI, Schenzle D. On the intra-host dynamics of HIV-1 infections. Math. Biosci. 2006;199:1-25.

Haase AT. Population biology of HIV-1 infection: viral and CD4+T cell demographics and dynamics in lymphatic tissues. Ann. Rev.Immunol. 1999;17:625-56.

Katubulushi M, Zulu I, Yavwa F, Kelly P. Slow decline in CD4 cell count in a cohort of HIV-infected adults living in Lusaka, Zambia. AIDS. 2005;19:102-3.

Detels R, English PA, Giorgi JV, Visscher BR, Fahey JL, Taylor JM, et al. Patterns of CD4+ cell changes after HIV-1 infection indicate the existence of a codeterminant of AIDS. JAIDS. 1988;1:390-5.

Lang W, Perkins H, Anderson RE, Royce R, Jewell N, Winkelstein W. Patterns of T lymphocyte changes with human immunodeficiency virus infection: from sero conversion to the development of AIDS. JAIDS. 1989;2:63-9.

Lyles RH, Munoz A, Yamashita TE, Bazmi H, Detels R, Rinaldo CR, et al. Natural history of human immunodeficiency virus type 1 viremia after seroconversion and proximal to AIDS in a large cohort of homosexual men. Multicenter AIDS Cohort Study. J. Infect. Dis. 2000;181:872-80.

Williams BG, Dye C. Antiretroviral drugs for tuberculosis control in the era of HIV/AIDS. Science. 2003;301:1535-7.

Williams BG, Hargrove JW, Humphrey JH. The benefits of early treatment for HIV. AIDS. 2010;24:1790-1.

Freedberg KA, Losina E, Weinstein MC, Paltiel AD, Cohen CJ, Seage GR, et al. The cost effectiveness of combination antiretroviral therapy for HIV disease. N. Engl. J. Med. 2001;344:824-31.

Hammer SM, Squires KE, Hughes MD. A controlled trialof two nucleoside analogues plus Indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. N Engl J Med. 1997;337:725-33.

Hogg RS, Yip B, Chan KJ. Rates of disease progression by baseline CD4 cell count and viral load after initiating Triple-Drug therapy. JAMA. 2001;286:2568-77.

Mocroft A, Phillips AN, Gatell J, Ledergerber B, Fisher M. Normalisation of CD4 counts in patients with HIV-1 infection and maximum virological suppression who are taking combination antiretroviral therapy: an observational COHORT study. 2007;370:407-13.

Gulick RM, Mellors JW, Havlir D, Eron JJ, Gonzalez C, McMahon D, et al. Treatment with indinavir, zidovudine and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy. New England Journal of Medicine. 1997;337:734-9.

Gracia F, de Lazzari E, Plana M, Castro P, Mestre G, Nomdedeu M, et al. Long- term CD4+ T-cell response to highly active antiretroviral therapy according to baseline CD4+ T-cell count. Journal Acquired Immune Deficiency Syndrome. 2004;36:702-13.

Patel AK, Pujari S, Patel K, Patel J, Shah N, Patel B, et al. Nevirapine versus Efavirenz based antiretroviral treatment in naïve Indian patients: comparison of effectiveness in clinical cohort. Journal of the Association of Physicians of India. 2006;54:915-8.